P

Paragon 28 Inc
NYSE:FNA

Watchlist Manager
Paragon 28 Inc
NYSE:FNA
Watchlist
Price: 10.35 USD 0.78% Market Closed
Market Cap: 866.5m USD
Have any thoughts about
Paragon 28 Inc?
Write Note

Net Margin
Paragon 28 Inc

-25.8%
Current
-23%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-25.8%
=
Net Income
-63.1m
/
Revenue
245m

Net Margin Across Competitors

Country US
Market Cap 865.2m USD
Net Margin
-26%
Country US
Market Cap 199.9B USD
Net Margin
14%
Country US
Market Cap 191.9B USD
Net Margin
29%
Country US
Market Cap 140.8B USD
Net Margin
16%
Country US
Market Cap 134.7B USD
Net Margin
11%
Country IE
Market Cap 104.7B USD
Net Margin
13%
Country US
Market Cap 65.9B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.8B USD
Net Margin
74%
Country CN
Market Cap 314.4B CNY
Net Margin
33%
Country US
Market Cap 36.4B USD
Net Margin
9%
No Stocks Found

Paragon 28 Inc
Glance View

Market Cap
865.2m USD
Industry
Health Care

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 343 full-time employees. The company went IPO on 2021-10-15. The firm develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The firm has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The firm has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). The company has commercial footprint across United States and International.

FNA Intrinsic Value
17.16 USD
Undervaluation 40%
Intrinsic Value
Price
P

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-25.8%
=
Net Income
-63.1m
/
Revenue
245m
What is the Net Margin of Paragon 28 Inc?

Based on Paragon 28 Inc's most recent financial statements, the company has Net Margin of -25.8%.